The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Open accessAbstract
Microdialysis in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D- and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter. However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and 5-HT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response. Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AMP increases the synaptic levels of monoamines (dopamine, noradrenaline and serotonin) by increasing their release through a reversal of the monoamine transporters, primarily the catecholamine transporters (see Fleckenstein et al., 2007; Hutson et al., 2014, for review; Kuczenski et al., 1995; Sulzer et al., 2005).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Kuczenski et al., 1995
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
Fischer, J. F., & Cho, A. K. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31549-1 · Cited by 443
Self-citationDetermination of Brain Interstitial Concentrations by Microdialysis
Benveniste, H., Hansen, A. J., & Ottosen, N. S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07252.x · Cited by 403
Kuczenski, R. T., & Segal, D. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Self-citationSulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Heikkila, R. E., Orlansky, H., Mytilineou, C., & Cohen, G. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30227-2 · Cited by 220
Berger, U. V., Gu, X. F., & Azmitia, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90023-w · Cited by 199
Segal, D. S., & Kuczenski, R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39192-5 · Cited by 177
Self-citationSampling considerations for on-line microbore liquid chromatography of brain dialysate
Wages, S. A., Church, W. H., & Justice, J. B. (1986) · Analytical Chemistry · doi:10.1021/ac00121a012 · Cited by 172
Globus, M. Y. ‐., Busto, R., Dietrich, W. D., Martinez, E., Valdés, I., & Ginsberg, M. D. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.123 · Cited by 165
Research works printed but not linked: 1
- Cole SO (1978) Brain mechanisms ofamohetamine-induced anorexia. locomdtion, And stereotypy: a review. fieurosci Biobehav Rev 2:891 100.
Cited by
Sorted by citations
Items 101–200 of 376
ADHD: Current and Future Therapeutics
Heal, D. J., Smith, S. L., & Findling, R. L. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_125 · Cited by 55
Erritzøe, D., Ashok, A. H., Searle, G. E., Colasanti, A., Turton, S., Lewis, Y. L., Huiban, M., Moz, S., Passchier, J., Saleem, A., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0567-5 · Cited by 54
Win‐Shwe, T., Mitsushima, D., Nakajima, D., Ahmed, S., Yamamoto, S., Tsukahara, S., Kakeyama, M., Goto, S., & Fujimaki, H. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.10.017 · Cited by 54
Borycz, J., Zapata, A. G., Quiroz, C., Volkow, N. D., & Ferré, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301445 · Cited by 53
GABA release in the medial preoptic area of cyclic female rats
Mitsushima, D., Shwe, T. T. W., Funabashi, T., Shinohara, K., & Kimura, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00160-4 · Cited by 54
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
Benedict, R. H. B., Munschauer, F. E., Zarevics, P., Erlanger, D. M., Rowe, V. D., Feaster, T. K., & Carpenter, R. L. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0760-7 · Cited by 53
L -amphetamine improves memory in MS patients with objective memory impairment
Sumowski, J. F., Chiaravalloti, N. D., Erlanger, D. M., Kaushik, T., Benedict, R. H. B., & DeLuca, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511404585 · Cited by 53
Kusljic, S., Copolov, D., & van den Buuse, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300277 · Cited by 53
Pharmacological treatment for memory disorder in multiple sclerosis
He, D., Zhang, Y., Dong, S., Wang, D., Gao, X., & Zhou, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876.pub3 · Cited by 52
Heal, D. J., Gosden, J., & Smith, S. L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.012 · Cited by 51
Pogorelov, V. M., Nomura, J., Kim, J., Kannan, G., Ayhan, Y., Yang, C., Taniguchi, Y., Abazyan, B. N., Valentine, H., Krasnova, I. N., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.003 · Cited by 52
Functional and Structural Brain Changes Associated with Methamphetamine Abuse
Jan, R. K., Kydd, R. R., & Russell, B. R. (2012) · Brain Sciences · doi:10.3390/brainsci2040434 · Cited by 52
Justinová, Z., Ferré, S., Segal, P. N., Antoniou, K. M., Solinas, M., Pappas, L. A., Highkin, J. L., Hockemeyer, J., Munzar, P., & Goldberg, S. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056762 · Cited by 51
Cadet, J. L., Jayanthi, S., McCoy, M. T., Ladenheim, B., Saint-Preux, F., Lehrmann, E., De, S., Becker, K. G., & Brannock, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-545 · Cited by 50
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
Self-citationSegal, D. S., & Kuczenski, R. T. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35066-9 · Cited by 48
Self-citationAmphetamine acts within the medial basal forebrain to initiate and maintain alert waking
Berridge, C. W., O’Neil, J. N., & Wifler, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00271-7 · Cited by 48
Mach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Gage, H. D., & Morton, T. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00449-2 · Cited by 48
Mayorga, A. J., Popke, E. J., Fogle, C. M., & Paule, M. G. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00165-5 · Cited by 47
Herrold, A. A., Shen, F., Graham, M. P., Harper, L. K., Specio, S. E., Tedford, C. E., & Napier, T. C. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.005 · Cited by 45
Lanctôt, K. L., Chau, S. A., Herrmann, N., Drye, L. T., Rosenberg, P. B., Scherer, R. W., Black, S. E., Vaidya, V., Bachman, D., & Mintzer, J. E. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001762 · Cited by 46
Bupropion attenuates methamphetamine self-administration in adult male rats
Reichel, C. M., Murray, J. E., Grant, K. M., & Bevins, R. A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.09.006 · Cited by 46
Gu, X., Yu, H., Jacobson, A. E., Rothman, R. B., Dersch, C. M., George, C. F., Flippen-Anderson, J. L., & Rice, K. C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000329v · Cited by 46
Melega, W. P., Cho, A. K., Schmitz, D. A., Kuczenski, R. T., & Segal, D. S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38016-4 · Cited by 46
Self-citationSchmeichel, B. E., & Berridge, C. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.6 · Cited by 43
Vanderschuren, L. J. M. J., Schoffelmeer, A. N. M., Wardeh, G., & Vries, T. J. D. (2000) · Psychopharmacology · doi:10.1007/s002130000424 · Cited by 43
Function of dopamine transporter is compromised in DYT1 transgenic animal modelin vivo
Hewett, J., Johansen, P., Sharma, N., Standaert, D. G., & Balcioglu, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06590.x · Cited by 45
Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats
Maki, Y., Inoue, T., Izumi, T., Muraki, I., Ito, K., Kitaichi, Y., Li, X., & Koyama, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00706-8 · Cited by 44
Baumann, M. H., AYESTAS, M. A., Sharpe, L. G., Lewis, D. B., Rice, K. C., & Rothman, R. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1190 · Cited by 44
Cerebral microglia mediate sleep/wake and neuroinflammatory effects of methamphetamine
Wisor, J. P., Schmidt, M. A., & Clegern, W. C. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.02.002 · Cited by 43
Cadet, J. L., Brannock, C., Ladenheim, B., McCoy, M. T., Krasnova, I. N., Lehrmann, E., Becker, K. G., & Jayanthi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084665 · Cited by 43
Markowitz, J. S., & Patrick, K. S. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0071 · Cited by 45
c-Myc inactivation by mutant max alters growth and morphology of NCI-H-630 colon cancer cells
Borrè, A., Cultraro, C. M., & Segal, S. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199610)169:1 · Cited by 10
Lin, K., Chou, W., Liu, T., Fang, C., Kuo, H., Kuo, P., Tsai, S., Wang, S., Chung, R., Tsou, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010721 · Cited by 42
Kaundal, M., Deshmukh, R. R., & Akhtar, M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.020 · Cited by 42
Adams, D. H., Hanson, G. R., & Keefe, K. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01507.x · Cited by 42
A comprehensive atlas of the topography of functional groups of the dopamine transporter
Volz, T. J., & Schenk, J. O. (2005) · Synapse · doi:10.1002/syn.20183 · Cited by 42
Monoaminergic Psychomotor Stimulants: Discriminative Stimulus Effects and Dopamine Efflux
Desai, R. I., Paronis, C. A., Martin, J., Desai, R., & Bergman, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165746 · Cited by 41
Bhardwaj, S. K., Beaudry, G., Quirion, R., Lévesque, D., & Srivastava, L. K. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.016 · Cited by 41
Appetite Suppressants as Agonist Substitution Therapies for Stimulant Dependence
Rothman, R. B., Blough, B. E., & Baumann, M. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04155.x · Cited by 41
Role of Endogenous Dopamine in the Neurochemical Deficits Induced by Methcathinone
Gygi, M. P., Fleckenstein, A. E., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37162-9 · Cited by 40
Schmeichel, B. E., Zemlan, F. P., & Berridge, C. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.005 · Cited by 40
Crawford, J. T., Roberts, D. C. S., & Beveridge, T. J. R. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.024 · Cited by 40
Steed, E., Jones, C. A., & McCreary, A. C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.026 · Cited by 38
Miyamoto, Y., Ishikawa, Y., Iegaki, N., Sumi, K., Fu, K., Sato, K., Furukawa‐Hibi, Y., Muramatsu, S., Nabeshima, T., Uno, K., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400011x · Cited by 37
Methamphetamine, Neurotransmitters and Neurodevelopment
Čechová, B., & Šlamberová, R. (2021) · Physiological Research · doi:10.33549/physiolres.934821 · Cited by 38
Neurobiological mechanisms and related clinical treatment of addiction: a review
Fang, Y., Sun, Y., Liu, Y., Liu, T., Hao, W., & Liao, Y. (2022) · Psychoradiology · doi:10.1093/psyrad/kkac021 · Cited by 39
UNIVERSIDADE DO EXTREMO SUL CATARINENSE - UNESC
Saúde, U. A. D., & Rosa, J. L. N. D. (2011) · Cited by 36
Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research
Yaşar, S., Goldberg, J., & Goldberg, S. R. (1996) · Springer eBooks · doi:10.1007/978-3-7091-7494-4_6 · Cited by 36
Motor function and dopamine release measurements in transgenic Huntington's disease model rats
Ortiz, A. N., Osterhaus, G. L., Lauderdale, K., Mahoney, L. A., Fowler, S. C., von Hörsten, S., Rieß, O., & Johnson, M. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.042 · Cited by 35
Thanos, P. K., Kim, R., Delis, F., Rocco, M. J., Cho, J. A., & Volkow, N. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.010 · Cited by 35
Swerdlow, N. R., Kuczenski, R. T., Goins, J., Crain, S. K., Lillian, T., Bongiovanni, M. J., & Shoemaker, J. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.11.002 · Cited by 35
Self-citationHäggkvist, J., Lindholm, S., & Franck, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.021 · Cited by 35
Sevak, R. J., Vansickel, A. R., Stoops, W. W., Glaser, P. E. A., Hays, L. R., & Rush, C. R. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318221b2db · Cited by 35
Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026409.76261.f3 · Cited by 35
Cadet, J. L., Brannock, C., Krasnova, I. N., Ladenheim, B., McCoy, M. T., Chou, J., Lehrmann, E., Wood, W. H., Becker, K. G., & Wang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015643 · Cited by 34
The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction
Zaniewska, M., Filip, M., & Przegaliński, E. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150121225659 · Cited by 35
Dexmedetomidine to Treat Lisdexamfetamine Overdose and Serotonin Toxidrome in a 6-Year-Old Girl
Akingbola, O., & Singh, D. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012768 · Cited by 34
da-Rosa, D. D., Valvassori, S. S., Steckert, A. V., Ornell, F. R., Ferreira, C. L., Lopes-Borges, J., Varela, R. B., Dal‐Pizzol, F., Andersen, M. L., & Quevedo, J. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.019 · Cited by 34
Schaun Korff, A., Stein, D. J., & Harvey, B. H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.025 · Cited by 35
Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats
Munzar, P., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050950 · Cited by 34
Kuczenski, R. T., Segal, D. S., Melega, W. P., Laćan, G., & McCunney, S. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.73 · Cited by 30
Self-citationKaushal, N., Seminerio, M. J., Shaikh, J., Medina, M. A., Mésangeau, C., Wilson, L., McCurdy, C. R., & Matsumoto, R. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.028 · Cited by 33
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 36
Chong, S. L., Claussen, C. M., & Dafny, N. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.004 · Cited by 34
Labonté, B., McLaughlin, R. J., Domínguez-López, S., Bambico, F. R., Lucchino, I., Ochoa‐Sanchez, R., Leyton, M., & Gobbi, G. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001544 · Cited by 33
Kitanaka, J., Kitanaka, N., Tatsuta, T., Morita, Y., & Takemura, M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.006 · Cited by 32
Wake-Promoting Medications: Basic Mechanisms and Pharmacology
Nishino, S., & Mignot, E. J.-M. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50045-8 · Cited by 32
Ginovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2 · Cited by 76
Self-citationJedema, H. P., Narendran, R., & Bradberry, C. W. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12743 · Cited by 30
Sae‐ung, K., Uéda, K., Govitrapong, P., & Phansuwan‐Pujito, P. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00927.x · Cited by 31
Munzar, P., Nosáľ, R., & Goldberg, S. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00789-4 · Cited by 31
Scardochio, T., & Clarke, P. B. S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2931-6 · Cited by 30
Padivitage, N., Dodbiba, E., Breitbach, Z. S., & Armstrong, D. W. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1534 · Cited by 30
Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys
Czoty, P. W., Makriyannis, A., & Bergman, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1798-6 · Cited by 30
Atomoxetine enhances a short-term model of plasticity in humans.
Foster, D. J., Good, D., Fowlkes, A. M., & Sawaki, L. (2006) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2005.08.131 · Cited by 32
D’Souza, M. S., Liechti, M. E., Ramirez-Niño, A. M., Kuczenski, R. T., & Markou, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.103 · Cited by 28
Self-citationDynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate
Kuczenski, R. T., & Segal, D. S. (1999) · Psychopharmacology · doi:10.1007/s002130051147 · Cited by 29
Self-citationCocaine and Methamphetamine Differentially Affect Opioid Peptide mRNA Expression in the Striatum
Adams, D. H., Hanson, G. R., & Keefe, K. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752061.x · Cited by 28
Swerdlow, N. R., Shoemaker, J. M., Kuczenski, R. T., Bongiovanni, M. J., Neary, A. C., Tochen, L. S., & Marie, R. L. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.060 · Cited by 29
Self-citationConti, L. H., Segal, D. S., & Kuczenski, R. T. (1997) · Psychopharmacology · doi:10.1007/s002130050227 · Cited by 29
Self-citationMunzar, P., Justinová, Z., Kutkat, S. W., & Goldberg, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01598-9 · Cited by 29
Reichel, C. M., Wilkinson, J. L., & Bevins, R. A. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f14efc · Cited by 28
Glezer, S., & Finberg, J. P. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01906-x · Cited by 28
Baumann, M. H., Williams, Z. R., Żółkowska, D., & Rothman, R. B. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.015 · Cited by 28
Emerging treatments for narcolepsy and its related disorders
Nishino, S., & Okuro, M. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903559852 · Cited by 28
Szumlinski, K. K., Balogun, M. Y., Maisonneuve, I. M., & Glick, S. D. (2000) · Psychopharmacology · doi:10.1007/s002130000478 · Cited by 28
Vouga, A. G., Gregg, R. A., Haidery, M., Ramnath, A., Al-Hassani, H. K., Tallarida, C. S., Grizzanti, D., Raffa, R. B., Smith, G. R., Reitz, A. B., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.010 · Cited by 27
Kitanaka, N., Kitanaka, J., Tatsuta, T., Tanaka, K., Watabe, K., Nishiyama, N., Morita, Y., & Takemura, M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0132-4 · Cited by 27
Napier, T. C., & Istre, E. D. (2007) · Synapse · doi:10.1002/syn.20460 · Cited by 27
Seminerio, M. J., Hansen, R., Kaushal, N., Zhang, H., McCurdy, C. R., & Matsumoto, R. R. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000831 · Cited by 26
da-Rosa, D. D., Valvassori, S. S., Steckert, A. V., Arent, C. O., Ferreira, C. L., Lopes-Borges, J., Varela, R. B., Mariot, E., Dal‐Pizzol, F., Andersen, M. L., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0691-9 · Cited by 26
Sánchez-Alavez, M., Conti, B., Wood, M. R., Bortell, N., Bustamante, E., Sáez, E., Fox, H. S., & Marcondes, M. C. G. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00044 · Cited by 26
Lan, K., Chang, A. C., Liu, S., Ho, I. K., & Lin‐Shiau, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05998.x · Cited by 26
Berridge, C. W., & Morris, M. F. (2000) · Psychopharmacology · doi:10.1007/s002130050055 · Cited by 26
Tin-Tin-Win-Shwe, Mitsushima, D., Shinohara, K., & Kimura, F. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.056 · Cited by 25
The role of cannabinoid 1 receptor expressing interneurons in behavior
Brown, J. A., Horváth, S., Garbett, K. A., Schmidt, M. J., Everheart, M., Gellért, L., Ebert, P. J., & Mirnics, K. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.001 · Cited by 25
Serotonergic imaging in Parkinson's disease
de Natale, E. R., Wilson, H., & Politis, M. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.11.001 · Cited by 25
Ferguson, S. A., Gough, B., & Cada, A. M. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00214-2 · Cited by 25
Escalating dose, multiple binge methamphetamine regimen does not impair recognition memory in rats
Clark, R. E., Kuczenski, R. T., & Segal, D. S. (2007) · Synapse · doi:10.1002/syn.20397 · Cited by 25
Self-citation
Metadata
- Authors
- Kuczenski, R., Segal, D., Cho, A., & Melega, W.
- Affiliations
- UC San Diego Health System (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1995-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 1308-1317
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6577819
- OpenAlex
- W1934404972
- Cited by
- 376
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 24 · 2013: 18 · 2012: 22
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da002411-13, 5r01da004157-14)
- U.S. Public Health Service
- National Institute on Drug Abuse (DA-01568, DA 02411, DA04157, R01DA001568)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, d-amphetamine, stereotypy, dopamine release, noradrenaline release, serotonin release, caudate nucleus, hippocampus, vesicular transporters, structure-activity relationship, microdialysis
- MeSH terms
- Amphetamine, Animals, Behavior, Animal, Caudate Nucleus, Dopamine, Hippocampus, Methamphetamine, Norepinephrine, Serotonin, Stereoisomerism, Stereotyped Behavior, Microdialysis, Neurotransmitter Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
